BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3069943)

  • 1. Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
    Hamaguchi K; Miyahara K; Nishimura H; Tashiro M; Kishi N; Matsumura T; Yakushiji M; Kato T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1755-9. PubMed ID: 3069943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC; Basler GA
    In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (γ, L-glutamic acid)-cisplatin bioconjugate exhibits potent antitumor activity with low toxicity: a comparative study with clinically used platinum derivatives.
    Feng Z; Lai Y; Ye H; Huang J; Xi XG; Wu Z
    Cancer Sci; 2010 Nov; 101(11):2476-82. PubMed ID: 20813014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preclinical evaluation of several cisplatinum analogs against human esophageal carcinoma by subrenal capsule assay].
    Terashima M; Ikeda K; Kawamura S; Takagane A; Maesawa C; Sudoh T; Okamoto K; Ishida K; Satoh M; Saito K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):269-73. PubMed ID: 2405778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Suzumori K; Yasui Y; Suzumori K; Yagami Y
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):387-91. PubMed ID: 2649007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M; Ozaki M; Taniguchi H; Tateishi R; Mori Y; Mino K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effect of JM-8 (a cisplatin analogue) on testicular cancer cells in vitro and in vivo].
    Hashimura T; Okada K; Yoshida O
    Gan To Kagaku Ryoho; 1985 May; 12(5):1137-42. PubMed ID: 3888118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK; Kim HT; Cho YB; Kim TS; Kim KH; Hong WS
    Anticancer Res; 1996; 16(1):251-6. PubMed ID: 8615617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H; Kubota T; Takahara T; Takeuchi T; Furukawa T; Kase S; Josui K; Kodaira S; Ishibiki K; Abe O
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.